BEUDAMED
    9 results · 8ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: FDA Class 2 ×

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·CORAB

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·CORAB

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·CORAB

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·CORAB

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST